StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen earnings per share — Diluted ($/sh) ($)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, Q2 2026
4.37
Period ended Jun 30, 2026
Change on a year earlier
+64.9%
2.65 in Q2 2025
History
55 quarters
Since Q2 2008
Sources
51
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEarnings per share — Diluted ($/sh) ($)Year on yearSource
Q2 2026Jun 30, 20264.37+64.9%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20263.34+4.4%Form 10-Q (filed 2026-05-01) ↗
Q3 2025Sep 30, 20255.93+13.6%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20252.65+92.0%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 20253.20-1,623.8%Form 10-Q (filed 2025-05-02) ↗
Q3 2024Sep 30, 20245.22+62.1%Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 20241.38-46.3%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024-0.21-104.0%Form 10-Q (filed 2024-05-03) ↗
Q3 2023Sep 30, 20233.22-19.1%Form 10-Q (filed 2023-10-31) ↗
Q2 2023Jun 30, 20232.57+4.9%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 20235.28+97.0%Form 10-Q (filed 2023-04-28) ↗
Q3 2022Sep 30, 20223.98–Form 10-Q (filed 2022-11-04) ↗
Q2 2022Jun 30, 20222.45–Form 10-Q (filed 2022-08-05) ↗
Q1 2022Mar 31, 20222.68-5.3%Form 10-Q (filed 2022-04-28) ↗
Q1 2021Mar 31, 20212.83-7.8%Form 10-Q (filed 2021-04-28) ↗
Q4 2020Dec 31, 20202.76–Form 10-K (filed 2021-02-09) ↗

Cite this data

StockData. (2026). Amgen Earnings per share — Diluted ($/sh) ($), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_eps_diluted

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.